Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Vasoactive intestinal peptide (VIP) (Tsukada T et al, 1985) ...
| Class:Id | Summation:420219 |
|---|---|
| _displayName | Vasoactive intestinal peptide (VIP) (Tsukada T et al, 1985) ... |
| _timestamp | 2009-05-11 13:38:09 |
| created | [InstanceEdit:420077] Jassal, Bijay, 2009-05-11 |
| text | Vasoactive intestinal peptide (VIP) (Tsukada T et al, 1985) belongs to the glucagon hormone family and is expressed in many parts of the human body. VIP causes vasodilation, lowers arterial blood pressure, stimulates myocardial muscle contraction and increases glycogenolysis. It also relaxes the smooth muscle of trachea, stomach and gall bladder. The effects of VIP are mediated by the VIP receptors of which there are two, 1 and 2 (Sreedharan SP et al, 1993 and Svodoba M et al, 1994 respectively). The actions of the receptor are mediated by coupling with the G protein alpha s subunit, which stimulates adenylyl cyclase which increases intracellular cAMP levels (Sreedharan SP et al, 1993). |
| (summation) | [Reaction:420233] VIP receptors bind VIP [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Vasoactive intestinal peptide (VIP) (Tsukada T et al, 1985) ... (420219)
